Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Jeffery Yap, Ph.D., and colleagues at the institute's nuclear medicine/PET department use the database to query previous patient studies. The database contains more than 100 parameters organized in a variety of tables to optimize data entry and retrieval. It provides PET acquisition time, FDG dose, uptake time, CT technique, and plasma glucose level, among other figures. The investigators presented their findings in a poster at the 2007 SNM meeting (J Nucl Med 2007;48[Suppl 2]:199P).
"We use this information to ensure each patient's scan is performed consistently for repeat visits," Yap said.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.